Naratriptan is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Naratriptan Hydrochloride.
| Product ID | 0054-0279_3fa2553a-28c7-47ba-999f-3448f20dedc4 |
| NDC | 0054-0279 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Naratriptan |
| Generic Name | Naratriptan |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-07-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090381 |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Substance Name | NARATRIPTAN HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2010-10-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090381 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-07 |
| Marketing End Date | 2016-06-13 |
| Marketing Category | ANDA |
| Application Number | ANDA090381 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-07 |
| Ingredient | Strength |
|---|---|
| NARATRIPTAN HYDROCHLORIDE | 2.5 mg/1 |
| SPL SET ID: | fd1944b3-8054-4faa-a82e-d818dfdd3875 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0278 | Naratriptan | Naratriptan |
| 0054-0279 | Naratriptan | Naratriptan |
| 0781-5527 | Naratriptan | Naratriptan |
| 23155-054 | naratriptan | naratriptan |
| 23155-055 | naratriptan | naratriptan |
| 42043-130 | Naratriptan | Naratriptan |
| 42043-131 | Naratriptan | Naratriptan |
| 50090-6162 | Naratriptan | Naratriptan |
| 69452-340 | Naratriptan | Naratriptan |
| 69452-341 | Naratriptan | Naratriptan |